LOADING
Comparing Merck & Company (MRK) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CSCO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $357.0B | $423.6B |
| P/E Ratio | 117.7 | 32.9 |
| Forward P/E | 15.2 | 20.4 |
| PEG Ratio | 2.87 | 1.01 |
| EPS | $1.23 | $3.27 |
| Revenue Growth (YoY) | 5.1% | 17.6% |
| Profit Margin | 4.8% | 20.9% |
| Return on Equity | 7.0% | 27.3% |
| Dividend Yield | 2.25% | 1.52% |
| Beta | 0.23 | 0.99 |
| 52-Week High | $156.92 | $129.88 |
| 52-Week Low | $75.81 | $65.00 |
| Volume | -- | -- |
Cisco Systems is the larger company by market capitalization. Cisco Systems trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.